Coronary heart disease
Conditions
Interventions
All participants:Danlou tablets, 1.5g, oral, three times a day
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1: Patients who were hospitalized for coronary heart disease and received PCI during hospitalization, or were hospitalized for other diseases but received PCI during hospitalization due to the appearance or aggravation of coronary heart disease symptoms, or were outpatients who received PCI for coronary heart disease in other hospitals within the past 2 weeks. Patients who met one of the above criteria and were diagnosed with phlegm and blood stasis syndrome by TCM met the inclusion criteria.
Exclusion criteria
Exclusion criteria: 1) Aged over 80 years old 2) Combined with malignant tumors and other diseases that seriously affect survival expectations 3) Children, minors and pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short-term adverse cardiovascular events; | — |
Countries
China
Contacts
Public ContactHou Xin-Zheng
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed